Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, PTC Therapeutics Inc’s stock clocked out at $45.77, up 1.19% from its previous closing price of $45.23. In other words, the price has increased by $1.19 from its previous closing price. On the day, 0.56 million shares were traded. PTCT stock price reached its highest trading level at $45.95 during the session, while it also had its lowest trading level at $44.58.
Ratios:
To gain a deeper understanding of PTCT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.04 and its Current Ratio is at 2.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on December 13, 2024, Upgraded its rating to Overweight and sets its target price to $67 from $45 previously.
On December 03, 2024, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $39 to $63.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 02 ’24 when Almstead Neil Gregory sold 69,550 shares for $52.06 per share. The transaction valued at 3,620,895 led to the insider holds 86,202 shares of the business.
Almstead Neil Gregory sold 2,060 shares of PTCT for $107,063 on Dec 02 ’24. The CHIEF TECHNICAL OPS OFFICER now owns 4,576 shares after completing the transaction at $51.97 per share. On Dec 02 ’24, another insider, ZELDIS JEROME B, who serves as the Director of the company, sold 24,000 shares for $51.50 each. As a result, the insider received 1,235,897 and left with 14,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PTCT now has a Market Capitalization of 3530016000 and an Enterprise Value of 4988888576. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.87. Its current Enterprise Value per Revenue stands at 5.539 whereas that against EBITDA is 228.345.
Stock Price History:
Over the past 52 weeks, PTCT has reached a high of $54.16, while it has fallen to a 52-week low of $23.58. The 50-Day Moving Average of the stock is 3.67%, while the 200-Day Moving Average is calculated to be 27.66%.
Shares Statistics:
It appears that PTCT traded 804.46K shares on average per day over the past three months and 563510 shares per day over the past ten days. A total of 76.95M shares are outstanding, with a floating share count of 74.46M. Insiders hold about 3.45% of the company’s shares, while institutions hold 101.75% stake in the company. Shares short for PTCT as of 1734048000 were 4590192 with a Short Ratio of 5.71, compared to 1731628800 on 4673031. Therefore, it implies a Short% of Shares Outstanding of 4590192 and a Short% of Float of 9.26.
